The constitutive activation of STAT3 is frequently detected in clinical samples from a wide range of human carcinoma such as multiple myeloma, glioblastoma, colorectal and hepatocellular carcinoma [22, 23]. This evidence concerns the gene STAT3 and plasma cell myeloma.